We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+14.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$13.1B
AUM Growth
-$2.14B
Cap. Flow
-$3.3B
Cap. Flow %
-25.17%
Top 10 Hldgs %
30.62%
Holding
2,094
New
695
Increased
393
Reduced
360
Closed
644

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$361M
2
META icon
Meta Platforms (Facebook)
META
+$187M
3
DUK icon
Duke Energy
DUK
+$104M
4
XOM icon
ExxonMobil
XOM
+$102M
5
INTC icon
Intel
INTC
+$66.4M

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Utilities 7.16%
3 Healthcare 6.86%
4 Industrials 6.78%
5 Real Estate 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
1701
iShares Core S&P Mid-Cap ETF
IJH
$126B
-1,200
Closed -$67K
ILMN icon
1702
Illumina
ILMN
$33.1B
-55,230
Closed -$7.48M
IMO icon
1703
Imperial Oil
IMO
$66.8B
-46,043
Closed -$2.63M
IMRX icon
1704
Immuneering
IMRX
$343M
-26,410
Closed -$194K
IMXI icon
1705
International Money Express
IMXI
$427M
-37,581
Closed -$830K
INBK icon
1706
First Internet Bancorp
INBK
$255M
-13,260
Closed -$321K
INGR icon
1707
Ingredion
INGR
$6.74B
-22,275
Closed -$2.42M
INMB icon
1708
INmune Bio
INMB
$64.4M
-14,948
Closed -$168K
INVZ icon
1709
Innoviz Technologies
INVZ
$101M
-78,335
Closed -$198K
IONQ icon
1710
IonQ
IONQ
$18.2B
-91,895
Closed -$1.14M
IQ icon
1711
iQIYI
IQ
$1.01B
-277,079
Closed -$1.35M
IR icon
1712
Ingersoll Rand
IR
$31.2B
-86,352
Closed -$6.68M
IRDM icon
1713
Iridium Communications
IRDM
$5.19B
-83,403
Closed -$3.43M
IREN icon
1714
Iris Energy
IREN
$15B
-34,283
Closed -$245K
IRWD icon
1715
Ironwood Pharmaceuticals
IRWD
$709M
-335,614
Closed -$3.84M
IA
1716
Innovative Solutions & Support
IA
$384M
-16,630
Closed -$142K
ISTR icon
1717
Investar Holding Corp
ISTR
$418M
-13,369
Closed -$199K
ITRI icon
1718
Itron
ITRI
$4.38B
-18,008
Closed -$1.36M
IVR icon
1719
Invesco Mortgage Capital
IVR
$809M
-193,878
Closed -$1.72M
J icon
1720
Jacobs Solutions
J
$17.6B
-16,082
Closed -$1.73M
JACK icon
1721
Jack in the Box
JACK
$331M
-49,274
Closed -$4.02M
JAMF
1722
DELISTED
Jamf
JAMF
-122,030
Closed -$2.2M
JBI icon
1723
Janus International
JBI
$697M
-28,791
Closed -$376K
JCI icon
1724
Johnson Controls International
JCI
$86.7B
-878,485
Closed -$50.6M
JD icon
1725
JD.com
JD
$39.7B
-201,435
Closed -$5.82M

Similar funds

Michael Gelband's Q1 2024 Portfolio in Review

As of Q1 2024, Michael Gelband held 2,094 positions worth $13.1B, down 14% from $15.2B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband withdrew a net $3.3B in Q1 2024, closing 644 positions and reducing 360 holdings. Its most notable exit was Fidelity National Information Services, an estimated $399M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.3% a quarter earlier, followed by Utilities and Healthcare.

Against the trend, Michael Gelband opened a new position in Duke Energy worth $106M.

  • Michael Gelband's largest Q1 2024 buy was Duke Energy: 1,098,157 shares worth $106M.
  • Michael Gelband added most to NVIDIA in Q1 2024, an estimated $361M increase.
  • Michael Gelband's biggest Q1 2024 reduction was CMS Energy, cutting an estimated $119M.
  • Michael Gelband fully exited Fidelity National Information Services in Q1 2024, selling an estimated $399M.
  • Michael Gelband's ten largest holdings make up 31% of its $13.1B portfolio in Q1 2024.
  • Michael Gelband opened 695 new positions and closed 644 in Q1 2024.
  • Michael Gelband's portfolio value fell 14% quarter-over-quarter to $13.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.